Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside pembrolizumab after surgery saw ...

Arcturus Therapeutics (NASDAQ:ARCT) President and CEO Joseph Payne outlined the company's messenger RNA programs, vaccine ...

A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and ...

When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in ...

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple organs, conventional treatments like surgery, radiation, and chemotherapy ...

Moderna MRNA announced that the Coalition for Epidemic Preparedness Innovations (“CEPI”) will invest up to $54.3 million in funding to support a pivotal phase III study evaluating its investigational ...

Scientists are increasingly looking at mRNA vaccines for cancer, not just viruses. The results of a study published in the journal Nature in October showed the promise of mRNA vaccines in fighting ...

LANSING, Mich. (WLNS) — Canceling federal mRNA vaccine projects threatens much more than pandemic response, according to Michigan State University’s Director of the Precision Health Program, Anna ...

Moderna became famous after it developed one of the leading coronavirus vaccines on the market. But the company's COVID-related work is no longer a major growth driver. Investors have instead been ...